Bausch + Lomb gains after report co exploring sale

Bausch + Lomb

16/09/2024 10:54

** U.S.-listed shares of Bausch + Lomb  BLCO.N  up 6% at
$16.48 premarket
    ** Eye care firm is exploring a sale as a way out of a messy
separation from its heavily indebted parent company that has
been opposed by lenders including Apollo Global Management,
Financial Times reported on Saturday
    ** The eye care business is working with advisers from
Goldman Sachs to test interest from potential buyers, people
familiar with the matter told FT
    ** Bausch + Lomb was likely to draw interest from private
equity groups, per report
    ** The company's market value was $5.47 bln up to Friday's
close, after losing ~9% so far this year

 (Reporting by Medha Singh)
 ((medha.singh@thomsonreuters.com))